MD Anderson Cancer Center Madrid-Espana

Madrid 28033

0 studies enrolling now · 2 studies all time

What they study most

Early Breast Cancer, Metastatic gpNMB Over-expressing Triple Negative Breast Cancer

Studies at this site

• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer — Completed